par Turcotte, Martin;Joensuu, Heikki;Kellokumpu-Lehtinen, Pirkko-Liisa;Sotiriou, Christos ;Smyth, Mark John;Stagg, John;Allard, David;Mittal, Deepak;Bareche, Yacine ;Buisseret, Laurence ;Jose, Vinu ;Pommey, Sandra;Delisle, Vincent;Loi, Sherene
Référence Cancer research, 77, 20, page (5652-5663)
Publication Publié, 2017-10
Référence Cancer research, 77, 20, page (5652-5663)
Publication Publié, 2017-10
Article révisé par les pairs
Titre: |
|
Auteur: | Turcotte, Martin; Joensuu, Heikki; Kellokumpu-Lehtinen, Pirkko-Liisa; Sotiriou, Christos; Smyth, Mark John; Stagg, John; Allard, David; Mittal, Deepak; Bareche, Yacine; Buisseret, Laurence; Jose, Vinu; Pommey, Sandra; Delisle, Vincent; Loi, Sherene |
Informations sur la publication: | Cancer research, 77, 20, page (5652-5663) |
Statut de publication: | Publié, 2017-10 |
Sujet CREF: | Cancérologie |
MeSH keywords: | 5'-Nucleotidase -- immunology |
Animals | |
Antibodies, Monoclonal -- immunology -- physiology | |
Antigens, CD -- immunology | |
Antigens, Neoplasm -- immunology | |
Breast Neoplasms -- immunology -- pathology -- therapy | |
Cell Line, Tumor | |
Disease Models, Animal | |
Drug Resistance, Neoplasm | |
Female | |
GPI-Linked Proteins -- immunology | |
Humans | |
Mice | |
Mice, Inbred BALB C | |
Mice, Transgenic | |
Molecular Targeted Therapy | |
Random Allocation | |
Receptor, ErbB-2 -- immunology | |
Signal Transduction | |
Tetraspanins -- immunology | |
Trastuzumab -- immunology -- pharmacology | |
Note générale: | SCOPUS: ar.j |
Langue: | Anglais |
Identificateurs: | urn:issn:0008-5472 |
info:doi/10.1158/0008-5472.CAN-17-0707 | |
info:pii/0008-5472.CAN-17-0707 | |
info:scp/85031419069 | |
info:pmid/28855210 |